How have HSAQ shares performed in 2024?

Health Sciences Acquisitions Co. 2's stock was trading at $9.13 at the beginning of 2024. Since then, HSAQ shares have decreased by 48.4% and is now trading at $4.71. View the best growth stocks for 2024 here .

What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Sciences Acquisitions Co. 2 investors own include Harbor Custom Development (HCDI) , Gores Holdings V (GRSVU) , FS Development (FSDC) , Freeline Therapeutics (FRLN) , Duck Creek Technologies (DCT) , CureVac (CVAC) , Checkmate Pharmaceuticals (CMPI) , Burlington Stores (BURL) , BigCommerce (BIGC) and KE (BEKE) .

When did Health Sciences Acquisitions Co. 2 IPO?

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an IPO on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

How do I buy shares of Health Sciences Acquisitions Co. 2?

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free HSAQ Stock Alerts

$4.71

+0.09 (+1.95%)

(As of 04/18/2024 ET)

Compare

Today's Range: $4.52
▼
$4.78
50-Day Range: $4.62
▼
$7.17
52-Week Range: $9.41
▼
$13.80

Volume: 30,144 shs
Average Volume: 205,918 shs
Market Capitalization: $52.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media

Get Health Sciences Acquisitions Co. 2 alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

HSAQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HSAQ Stock News Headlines

April 9, 2024 | americanbankingnews.com

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Stock Price Up 0.8%

February 16, 2024 | msn.com

Xoma to acquire Kinnate Biopharma for $2.3352 - $2.5879 per share

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

November 7, 2023 | msn.com

Precision BioSciences GAAP EPS of -$0.07, revenue of $13.12M

August 16, 2023 | axios.com

JPMorgan, Oppenheimer advising Cano Health

August 7, 2023 | latimes.com

NIH ices research on health communication and misinformation. Is it self-censorship?

April 13, 2023 | bizjournals.com

Healthcare and life sciences industry leaders optimistic despite historic upheavals and great uncertainty

April 11, 2023 | markets.businessinsider.com

DISCOVERY LIFE SCIENCES ACQUIRES REACHBIO RESEARCH LABS

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 27, 2023 | finance.yahoo.com

Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model

January 24, 2023 | usnews.com

What You Need to Know About Becoming a Health Science Major

January 6, 2023 | finance.yahoo.com

Health Sciences Acquisitions Corporation 2 (HSAQ)

September 20, 2022 | finance.yahoo.com

Orchestra BioMed™ Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT™ at TCT 2022

September 16, 2022 | msn.com

From sports tech to health care, Boston is exporting innovation

September 16, 2022 | forbes.com

Addressing The Disconnect Between American Healthcare And Modern Society

September 13, 2022 | msn.com

Free preventive care under the ACA is under threat again – a ruling exempting PrEP from insurance coverage may extend nationwide and to other health services

September 13, 2022 | msn.com

AnPac Bio-Medical Sciences faces possible stock exchange delisting due to stock price

September 13, 2022 | finance.yahoo.com

Numinus provides update on acquisition integration and announces new client financing options

September 13, 2022 | finance.yahoo.com

New Research from the Clarify Health Institute Highlights the Severity of Pediatric Mental Health Conditions in the United States

September 12, 2022 | news.yahoo.com

Children’s mental health issues have increased, insurance claims suggest

September 12, 2022 | cnbc.com

This little-known senior health care stock can surge more than 60%, Goldman Sachs says

September 9, 2022 | msn.com

I wouldn’t spend money on microbiome skincare products. The science isn’t there | Opinion

September 9, 2022 | markets.businessinsider.com

$11.3 million NIH Superfund award to address environmental health issues caused by VOCs

September 9, 2022 | wsj.com

Affordable Care Act Health-Plan Premiums Set to Rise

September 7, 2022 | apnews.com

Biophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory Failure

September 2, 2022 | benzinga.com

AfterShip Announces SOC 2 Compliance, Taking "Enterprise Ready" to the Next Level

August 30, 2022 | reuters.com

HSAQ.OQ - | Stock Price & Latest News | Reuters

See More Headlines

Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:HSAQ
CUSIP: N/A
CIK: 1814114
Web: N/A
Phone: N/A
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-380,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -2.38%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.17
Quick Ratio: 0.61

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.62) per share
Price / Book: -7.60

Miscellaneous

Outstanding Shares: 11,212,000
Free Float: 8,757,000
Market Cap: $52.81 million
Optionable: Not Optionable
Beta: 0.09

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Roderick Tze Ian Wong M.D. (Age 46)
Pres, CEO & Chairman
Dr. Naveen Yalamanchi M.D. (Age 46)
Exec. VP, CFO & Director
Ms. Alice Lee J.D. (Age 52)
VP of Operations, Sec. & Treasurer
Ms. Stephanie A. Sirota (Age 47)
VP of Corp. Strategy & Corp. Communications

Key Competitors

View All Competitors

HSAQ Stock Analysis - Frequently Asked Questions

How have HSAQ shares performed in 2024?: Health Sciences Acquisitions Co. 2's stock was trading at $9.13 at the beginning of 2024. Since then, HSAQ shares have decreased by 48.4% and is now trading at $4.71.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Health Sciences Acquisitions Co. 2 investors own include Harbor Custom Development (HCDI), Gores Holdings V (GRSVU), FS Development (FSDC), Freeline Therapeutics (FRLN), Duck Creek Technologies (DCT), CureVac (CVAC), Checkmate Pharmaceuticals (CMPI), Burlington Stores (BURL), BigCommerce (BIGC) and KE (BEKE).
When did Health Sciences Acquisitions Co. 2 IPO?: Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an IPO on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.
How do I buy shares of Health Sciences Acquisitions Co. 2?: Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSAQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial